Stay updated on Combined GSK2398852/GSK2315698 in Multiple Treatment Sessions Clinical Trial

Sign up to get notified when there's something new on the Combined GSK2398852/GSK2315698 in Multiple Treatment Sessions Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Combined GSK2398852/GSK2315698 in Multiple Treatment Sessions Clinical Trial page

  1. Check
    3 days ago
    Change Detected
    Summary
    Updated the page revision from v3.0.1 to v3.0.2 and removed the Back to Top element.
    Difference
    0.1%
    Check dated 2025-09-14T18:48:57.000Z thumbnail image
  2. Check
    10 days ago
    Change Detected
    Summary
    The web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content. There are no significant changes to core content or important information.
    Difference
    0.1%
    Check dated 2025-09-07T13:15:30.000Z thumbnail image
  3. Check
    17 days ago
    Change Detected
    Summary
    The web page has undergone significant updates, including the addition of a facility name and location, as well as the introduction of new medical terms such as 'dezamizumab' and 'miridesap'. The revision number has also been updated from v2.16.12 to v3.0.0.
    Difference
    0.4%
    Check dated 2025-08-31T11:10:38.000Z thumbnail image
  4. Check
    24 days ago
    No Change Detected
  5. Check
    31 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.16.11 to version 2.16.12.
    Difference
    0.0%
    Check dated 2025-08-17T00:34:17.000Z thumbnail image
  6. Check
    38 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.16.10 to version 2.16.11.
    Difference
    0.0%
    Check dated 2025-08-09T20:10:26.000Z thumbnail image
  7. Check
    46 days ago
    Change Detected
    Summary
    The web page has been updated to include detailed information about a clinical study evaluating the effects of GSK2398852 and GSK2315698 on cardiac amyloidosis, including study objectives, participant criteria, and treatment protocols. Additionally, it emphasizes that the U.S. government does not review or approve the safety and science of all studies listed on the site.
    Difference
    100%
    Check dated 2025-08-02T15:21:57.000Z thumbnail image

Stay in the know with updates to Combined GSK2398852/GSK2315698 in Multiple Treatment Sessions Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Combined GSK2398852/GSK2315698 in Multiple Treatment Sessions Clinical Trial page.